Full data view for gene TSC2

The curator’s expert opinion on the classification of a variant, can be found in the
SUMMARY record. Regarding the classification, please note that where there are several
records of the same variant, the classification of that variant may differ depending on the
submitter’s conclusion.
Information The variants shown are described using the NM_000548.3 transcript reference sequence.

3 entries on 1 page. Showing entries 1 - 3.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

P-domain     

Predict-BioInf     

Allele     

Classification method     

Clinical classification     

DNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Template     

Technique     

Tissue     

Remarks     

Disease     

ID_report     

Reference     

Remarks     

Gender     

Consanguinity     

Country     

Population     

Age at death     

VIP     

Data_av     

Treatment     

Panel size     

Owner     
+/. 30 c.3441_3442delinsTT r.(?) p.(Gln1148*) - - Unknown - pathogenic g.2130209_2130210delinsTT g.2080208_2080209delinsTT c.3441_3442CC>TT; p.Q1148? - TSC2_002447 variant in facial angiofibroma, absent in normal skin; 2bp CC del, 2bp TT ins; Sanger SEQ confirmed; tumour MAF in freq column; blood or saliva also tested; NGS median read-depth of >5000x PubMed: Tyburczy, 2014 - - Somatic - 0.47 +DdeI, BslI- - - DNA SEQ-NG-I, SEQ Tumour, Normal Skin - TSC P5 PubMed: Tyburczy, 2014 childhood onset and diagnosis of TSC; patient has TSC2 germline c.1074G>A and four TSC2 somatic variants c.3441_3442delinsTT, c.5228_5229delinsAA and TSC2 deletions of ex.2-26 and ex.4-43 F - - - - - - - 1 Rosemary Ekong
+/. 30 c.3441_3442delinsTT r.(?) p.(Gln1148*) - - Unknown - pathogenic g.2130209_2130210delinsTT g.2080208_2080209delinsTT - - TSC2_002447 found with somatic TSC2 c.1108C>T in facial angiofibromas (variant MAF = 2.08% in facial angiofibromas) and with germline TSC2 c.2628_2634del PubMed: Giannikou, 2019 - - Somatic ? - - - - DNA SEQ-NG-I Blood, Skin, Saliva variant identified by targeted massively parallel sequencing at 300 to 1200-fold read depth, validated by amplicon massively parallel sequencing at 25,000 to 1,000,000-fold read depth TSC S20 PubMed: Giannikou, 2019 23 yr old patient with low level mosaicism; has TSC2 germline c.2628_2634delCAACCCC and two TSC2 somatic variants (c.3441_3442delinsTT and c.1108C>T) F ? (United States) - - - - - 1 Rosemary Ekong
+/+ 30 c.3441_3442delinsTT r.(?) p.(Gln1148*) - - Unknown - pathogenic (dominant) g.2130209_2130210delinsTT g.2080208_2080209delinsTT - - TSC2_002447 - - - - SUMMARY record - - DdeI+, BslI- - - - - - - - - - - - - - - - - - - - -
Legend   How to query  

Assessment of functional consequences - Our conclusions on the functional consequences of variants are based on the type of variant, results of in vitro functional tests (doi: 10.1002/humu.21451; doi: 10.1002/humu.22202; doi: 10.1002/humu.23963), population frequencies, output from in silico splice site prediction algorithms, and any clinical/family data available to us. We also have output from protein prediction programs in this database for comparison purposes and they are not considered in our assessment of pathogenicity. PolyPhen Predictions - Note that these results are from PolyPhen-2 and only the HumDiv classification is shown.


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.